Internal Medicine, Gastroenterology · Indianapolis, IN
NPI
1023264900
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1701 N Senate Blvd
Indianapolis, IN, 46202
Phone (888) 484-3258
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
416 services
Medicare patients, 2024
261
Average age 68
Drug cost, 2024
$5.6M
1,060 prescriptions
Company payments, 2025
$74K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Monika Fischer was code 99214 (office e&m - established), 65 times for 62 patients. In total Monika Fischer billed 416 services in 29 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 65 | 62 | $88.87 | $5,776 |
| 45385 Colonoscopy - Lesion Removal | Facility | 49 | 48 | $192.71 | $9,443 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 20 | $58.17 | $2,501 |
| 99214 Office E&M - Established | Facility | 36 | 33 | $59.26 | $2,133 |
| 43235 Upper GI Endoscopy | Facility | 26 | 26 | $78.32 | $2,036 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 20 | 20 | $159.05 | $3,181 |
| 45378 Lower GI Endoscopy - Other | Facility | 20 | 20 | $119.70 | $2,394 |
| 45380 Lower GI Endoscopy - Other | Facility | 20 | 18 | $113.53 | $2,271 |
| 99215 Office E&M - Established | Office | 19 | 18 | $128.05 | $2,433 |
| 43239 Upper GI Endoscopy | Facility | 15 | 15 | $76.74 | $1,151 |
| 99233 Hospital E&M - Subsequent | Facility | 15 | 11 | $87.53 | $1,313 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $96.03 | $1,344 |
By year: 2022 $36K for 416 services; 2023 $41K for 405 services; 2024 $46K for 416 services.
Medicare prescription drug claims, 2024
In 2024, the drug Monika Fischer prescribed most often to Medicare patients was Stelara (Ustekinumab), with 87 prescriptions and refills. In total Monika Fischer wrote 1,060 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 87 | 98 | 13 | $2.3M |
| Skyrizi On-Body Risankizumab-Rzaa | 87 | 146 | 18 | $1.8M |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 82 | 82 | 79 | $1,043 |
| Omeprazole Generic | 75 | 168 | 25 | $1,356 |
| Mesalamine Generic | 44 | 95 | 15 | $22K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 36 | 36 | 35 | $2,104 |
| Colestipol Hcl Generic | 35 | 59 | 11 | $3,840 |
| Azathioprine Generic | 32 | 86 | Under 11 | $1,522 |
| Pantoprazole Sodium Generic | 31 | 49 | Under 11 | $182 |
| Humira(Cf) Pen Adalimumab | 31 | 47 | Under 11 | $497K |
| Rinvoq Upadacitinib | 28 | 28 | Under 11 | $225K |
| Loperamide Loperamide Hcl | 26 | 45 | Under 11 | $1,822 |
| Sodium Chloride 0.9 % Sodium Chloride | 23 | 32 | Under 11 | $73.5 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 23 | 47 | Under 11 | $2,956 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 22 | 22 | 22 | $305 |
Brand drugs: - claims; generic drugs: 624 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Monika Fischer $74K ($74K in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $57K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 47 | $57K |
| Lilly USA, LLC LLY | 8 | $8,888 |
| Pfizer Inc. PFE | 9 | $6,713 |
| Abbvie Inc. ABBV | 16 | $1,034 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $40 |
| Aimmune Therapeutics, Inc. | 1 | $33.48 |
| Ironwood Pharmaceuticals, Inc IRWD | 1 | $24.45 |
| Genentech, Inc. ROG.SW | 1 | $19.81 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $6.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.